Although the Australian blood supply is among the safest in the world, homologous transfusion is not risk-free. In some circumstances, alternatives are available or being developed. Clinicians need to be aware of the risks, benefits and options in transfusion therapy and to fully inform patients of these.
No takes yet. Share an insight, caveat, or question.
Pink et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: